Reading Time: < 1 minuteNovember has been an incredibly busy time for us, not because of Christmas, but because the 23rd International Symposium on ALS/MND is now only one week away!
Tag: International Symposium on ALS/MND
Reading Time: 3 minutesPromising results from a Phase II clinical trial for a drug called NP001 have been announced by the biopharmaceutical company Neuraltus. The trial, conducted in America, suggested
Reading Time: 2 minutesWe organise the International Symposium on ALS/MND every year, and it is regarded as the premier medical conference on MND and a highlight of the
Reading Time: < 1 minuteAttending a three day scientific meeting is quite an intense experience, my brain has been working hard and by this morning, there were leaks of
Reading Time: 3 minutesModels of MND are important both to understand the causes of MND and to quickly, efficiently and accurately screen and develop new treatments for it.
Reading Time: 3 minutes“After a time where patients and sponsors of trials alike had become disheartened about the lack of positive clinical trials, it is exciting to see
Reading Time: 2 minutesPeople at increased risk of MND might be the human equivalent of high performance cars – built for speed and agility but becoming unreliable once
Reading Time: 2 minutesAt the end of the opening session of the International Symposium on ALS/MND, two members of the MND research community were recognised for their contribution